Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$2,623,095
+$340,320 QoQ
Shares Held
10,424
-0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#1,746
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BSW Wealth Partners holds $16,171,442 across 12 Drug Manufacturers - General names. ABBV ranks #2 (16.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,390 | $4,066,068 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
10,424 | $2,623,095 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,580 | $2,259,030 | |
| 4 | PFE |
Pfizer Inc
|
66,011 | $1,589,544 | |
| 5 | JNJ |
Johnson & Johnson
|
5,260 | $1,335,882 | |
| 6 | AMGN |
Amgen Inc
|
2,598 | $940,787 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
14,637 | $843,383 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,275 | $792,783 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,623,095 | 10,424 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $2,282,775 | 10,496 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $2,359,616 | 10,327 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,508,041 | 10,832 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $1,800,885 | 9,702 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $2,088,076 | 9,966 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $2,039,107 | 11,475 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,895,018 | 9,596 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,545,395 | 9,010 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $1,623,785 | 8,917 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,431,457 | 9,237 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $1,395,052 | 9,359 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,244,770 | 9,239 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,582,384 | 9,929 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,618,685 | 10,016 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,329,215 | 9,904 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,509,391 | 9,855 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,541,666 | 9,510 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,175,949 | 8,685 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $659,193 | 6,111 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $751,534 | 6,672 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $772,041 | 7,134 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $928,454 | 8,665 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $688,194 | 7,857 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $792,901 | 8,076 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $544,910 | 7,152 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||